{"id":646573,"date":"2023-04-11T19:06:01","date_gmt":"2023-04-11T19:06:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=646573"},"modified":"2023-04-11T19:06:01","modified_gmt":"2023-04-11T19:06:01","slug":"staphylococcus-aureus-bacteremia-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-trellis-bioscience-legochem-biosciences-aptorum","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/staphylococcus-aureus-bacteremia-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-trellis-bioscience-legochem-biosciences-aptorum_646573.html","title":{"rendered":"Staphylococcus aureus Bacteremia Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies &#8211; Trellis Bioscience, LegoChem Biosciences, Aptorum"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1681211986.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Staphylococcus aureus Bacteremia Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies - Trellis Bioscience, LegoChem Biosciences, Aptorum\" src=\"https:\/\/www.abnewswire.com\/uploads\/1681211986.jpeg\" alt=\"Staphylococcus aureus Bacteremia Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies - Trellis Bioscience, LegoChem Biosciences, Aptorum\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u201cStaphylococcus aureus Bacteremia Market Insights, Epidemiology, and Market Forecast-2032\u2033 report offers an in-depth understanding of the Staphylococcus aureus Bacteremia.<\/div>\n<p style=\"text-align: justify;\">DelveInsight&rsquo;s <strong>&ldquo;Staphylococcus aureus Bacteremia Market Insights, Epidemiology, and Market Forecast-2032&Prime;<\/strong> report offers an in-depth understanding of the Staphylococcus aureus Bacteremia, historical and forecasted epidemiology as well as the Staphylococcus aureus Bacteremia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>To Know in detail about the Staphylococcus aureus Bacteremia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/staphylococcus-aureus-bacteremia-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Staphylococcus aureus Bacteremia Market Forecast<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the Staphylococcus aureus Bacteremia Market Report:&nbsp;<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The Staphylococcus aureus Bacteremia market size is anticipated to grow with a significant <strong>CAGR<\/strong> during the study period <strong>(2019-2032)<\/strong><\/li>\n<li>As per <strong>CDC (2019)<\/strong>, estimates about two in every 100 people carry MRSA. Approximately5%of patients in US hospitals carry MRSA in their nose or on their skin, although most of them do not develop serious MRSA infections<\/li>\n<li>As per <strong>Naber et al. (2009)<\/strong>, S. aureus is one of the most dominant causes of nosocomial bacteremia, hospital acquired pneumonia, and surgical site infections<\/li>\n<li>As per <strong>Van Hal et al. (2012)<\/strong>, S. aureus bacteremia is estimated with an incidence rate ranging from 20 to 50 cases per 100,000 population per year<\/li>\n<li><strong>Key Staphylococcus aureus Bacteremia Companies:<\/strong> Trellis Bioscience, LegoChem Biosciences, Aptorum Group, ContraFect, Crystalgenomics, Cellics Therapeutics, MicuRx, Oxford Antibiotic Group, Destiny Pharma, TSRL, Inc., TAXIS Pharmaceuticals, Basilea Pharmaceutica, Helperby Therapeutics, Akagera Medicines, Histogen, Alphamab Co. Ltd, Biocidium Pharmaceuticals, and others<\/li>\n<li><strong>Key Staphylococcus aureus Bacteremia Therapies:<\/strong> Ceftobiprole, AP-SA02, XF-73, Aurexis&reg;, Ceftaroline fosamil, CF-301, and others<\/li>\n<li>The Staphylococcus aureus Bacteremia epidemiology based on gender analyzed that male gender is consistently associated with increased SAB incidence with male-to-female ratios of &sim;1.5<\/li>\n<li>The Staphylococcus aureus Bacteremia market is expected to surge due to the disease&#8217;s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Staphylococcus aureus Bacteremia pipeline products will significantly revolutionize the Staphylococcus aureus Bacteremia market dynamics.<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Staphylococcus aureus Bacteremia Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">Staphylococcus aureus (S. aureus) is a gram-positive bacterium and a causative agent of healthcare-associated infections from both community-acquired and hospital-acquired bacteremia.It causes a wide range of diseases from mild to a life-threatening condition, and a leading cause of bacteremia and infective endocarditis (IE).<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Get a Free sample for the Staphylococcus aureus Bacteremia Market Report &#8211;&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/staphylococcus-aureus-bacteremia-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">https:\/\/www.delveinsight.com\/sample-request\/staphylococcus-aureus-bacteremia-pipeline-insight<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Staphylococcus aureus Bacteremia Epidemiology<\/strong><\/p>\n<p style=\"text-align: justify;\">The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Staphylococcus aureus Bacteremia Epidemiology Segmentation:<\/strong><\/p>\n<p style=\"text-align: justify;\">The Staphylococcus aureus Bacteremia market report proffers epidemiological analysis for the study period 2019&ndash;2032 in the 7MM segmented into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Total Prevalence of Staphylococcus aureus Bacteremia<\/li>\n<li>Prevalent Cases of Staphylococcus aureus Bacteremia by severity<\/li>\n<li>Gender-specific Prevalence of Staphylococcus aureus Bacteremia<\/li>\n<li>Diagnosed Cases of Episodic and Chronic Staphylococcus aureus Bacteremia<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Download the report to understand which factors are driving Staphylococcus aureus Bacteremia epidemiology trends @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/staphylococcus-aureus-bacteremia-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Staphylococcus aureus Bacteremia Epidemiology Forecast<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Staphylococcus aureus Bacteremia Drugs Uptake and Pipeline Development Activities<\/strong><\/p>\n<p style=\"text-align: justify;\">The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Staphylococcus aureus Bacteremia market or expected to get launched during the study period. The analysis covers Staphylococcus aureus Bacteremia market uptake by drugs, patient uptake by therapies, and sales of each drug.&nbsp;<\/p>\n<p style=\"text-align: justify;\">Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.<\/p>\n<p style=\"text-align: justify;\">The report also covers the Staphylococcus aureus Bacteremia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Staphylococcus aureus Bacteremia Therapies and Key Companies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Ceftobiprole:<\/strong> Basilea Pharmaceutica<\/li>\n<li><strong>AP-SA02:<\/strong> Armata Pharmaceuticals, Inc.<\/li>\n<li><strong>XF-73:<\/strong> Destiny Pharmaceuticals<\/li>\n<li><strong>Aurexis&reg;:<\/strong> Bristol-Myers Squibb<\/li>\n<li><strong>Ceftaroline fosamil:<\/strong> Forest Laboratories<\/li>\n<li><strong>CF-301:<\/strong> ContraFect<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Discover more about therapies set to grab major Staphylococcus aureus Bacteremia market share @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/staphylococcus-aureus-bacteremia-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Staphylococcus aureus Bacteremia Treatment Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Staphylococcus aureus Bacteremia Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Study Period: 2019&ndash;2032<\/strong><\/li>\n<li><strong>Coverage:<\/strong> 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]<\/li>\n<li><strong>Key Staphylococcus aureus Bacteremia Companies:<\/strong> Trellis Bioscience, LegoChem Biosciences, Aptorum Group, ContraFect, Crystalgenomics, Cellics Therapeutics, MicuRx, Oxford Antibiotic Group, Destiny Pharma, TSRL, Inc., TAXIS Pharmaceuticals, Basilea Pharmaceutica, Helperby Therapeutics, Akagera Medicines, Histogen, Alphamab Co. Ltd, Biocidium Pharmaceuticals, and others<\/li>\n<li><strong>Key Staphylococcus aureus Bacteremia Therapies:<\/strong> Ceftobiprole, AP-SA02, XF-73, Aurexis&reg;, Ceftaroline fosamil, CF-301, and others<\/li>\n<li><strong>Staphylococcus aureus Bacteremia Therapeutic Assessment:<\/strong> Staphylococcus aureus Bacteremia current marketed and Staphylococcus aureus Bacteremia emerging therapies<\/li>\n<li><strong>Staphylococcus aureus Bacteremia Market Dynamics:<\/strong>&nbsp;Staphylococcus aureus Bacteremia market drivers and Staphylococcus aureus Bacteremia market barriers&nbsp;<\/li>\n<li><strong>Competitive Intelligence Analysis:<\/strong> SWOT analysis, PESTLE analysis, Porter&rsquo;s five forces, BCG Matrix, Market entry strategies<\/li>\n<li><strong>Staphylococcus aureus Bacteremia Unmet Needs, KOL&rsquo;s views, Analyst&rsquo;s views, Staphylococcus aureus Bacteremia Market Access and Reimbursement&nbsp;<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>To know more about Staphylococcus aureus Bacteremia companies working in the treatment market, visit @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/staphylococcus-aureus-bacteremia-pipeline-insight?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Staphylococcus aureus Bacteremia Clinical Trials and Therapeutic Assessment<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Staphylococcus aureus Bacteremia Market Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary for Staphylococcus aureus Bacteremia<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis of Staphylococcus aureus Bacteremia<\/p>\n<p style=\"text-align: justify;\">4. Staphylococcus aureus Bacteremia Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Staphylococcus aureus Bacteremia Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Staphylococcus aureus Bacteremia Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Staphylococcus aureus Bacteremia Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Staphylococcus aureus Bacteremia&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Staphylococcus aureus Bacteremia Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Staphylococcus aureus Bacteremia Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Staphylococcus aureus Bacteremia Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Staphylococcus aureus Bacteremia Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Staphylococcus aureus Bacteremia Market Analysis (2019&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Staphylococcus aureus Bacteremia Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Staphylococcus aureus Bacteremia Market Drivers<\/p>\n<p style=\"text-align: justify;\">16. Staphylococcus aureus Bacteremia Market Barriers<\/p>\n<p style=\"text-align: justify;\">17.&nbsp; Staphylococcus aureus Bacteremia Appendix<\/p>\n<p style=\"text-align: justify;\">18. Staphylococcus aureus Bacteremia Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.<\/p>\n<p style=\"text-align: justify;\">It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_75613.html\" rel=\"nofollow\">DelveInsight Business Research<\/a><br \/><strong>Contact Person:<\/strong> Gaurav Bora<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=staphylococcus-aureus-bacteremia-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-trellis-bioscience-legochem-biosciences-aptorum\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 8774225362<br \/><strong>Address:<\/strong>27 Drydock Ave  S. Jones Blvd #2432<br \/><strong>City:<\/strong> Boston<br \/><strong>State:<\/strong> MA<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/consulting\/asset-prioritizaton-services\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/consulting\/asset-prioritizaton-services<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/consulting\/asset-prioritizaton-services\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=staphylococcus-aureus-bacteremia-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-trellis-bioscience-legochem-biosciences-aptorum\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight\u2019s \u201cStaphylococcus aureus Bacteremia Market Insights, Epidemiology, and Market Forecast-2032\u2033 report offers an in-depth understanding of the Staphylococcus aureus Bacteremia. DelveInsight&rsquo;s &ldquo;Staphylococcus aureus Bacteremia Market Insights, Epidemiology, and Market Forecast-2032&Prime; report offers an in-depth understanding of the Staphylococcus aureus Bacteremia, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/staphylococcus-aureus-bacteremia-market-to-register-incremental-growth-during-the-forecast-period-20222032-asserts-delveinsight-key-companies-trellis-bioscience-legochem-biosciences-aptorum_646573.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,423],"tags":[],"class_list":["post-646573","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/646573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=646573"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/646573\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=646573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=646573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=646573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}